We monitored the progression of the inflammatory response by quantifying the clinical signs of systemic inflammation (mMSS), body temperature, and plasma IL-6 levels, a reliable biomarker of systemic inflammation and sepsis-related morbidity. Here, IL6 is linked to Sepsis.